Privacy Policy
Signals Blog

Contributors

Categories

Can COVID-19 be a shot in the arm for cell and gene therapy?

Phil Vanek is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil...

Right Turn: Lots to ponder in genetics documentary

When you hear the term “playing God” does it make you think of science? I will wager yes and that you connect the two even more after watching the docuseries “Unnatural Selection” on Netflix. I watched it for the purposes of this blog, but quickly became engrossed in...

Highlights of my first trip to virtual Paris, courtesy of ISCT

Glenn MacLean is a Development Manager at CCRM where his focus is supporting company creation.  Glenn obtained his PhD from Queen’s University while studying the role of retinoic acid metabolism during embryonic development. For post-doctoral studies, Glenn studied...